NSB
Click for more information
0.00% 3.9¢ neuroscientific biopharmaceuticals ltd

Ann: Investor Update Webinar, page-40

  1. tonymcm
    59 Posts.
    lightbulb Created with Sketch. 12
    clock Created with Sketch.
    07/09/22
    15:52
    Post #: 63569116
    To be honest ant590 I have been bemused around their decision to run an "early phase" phase 1 trial preceeding their (so called) real phase 1. Perhaps the HREC are equally confused and were unprepared to give this trial approval until they had the early phase trial data. As you rightly say 80 pax in a phase 1 is unusual. I would love to know who's driving their clinical strategy. Frankly its time to hear directly from the board chair.
    NSB Price at posting: 7.9¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
3.9¢ 		Change
0.000(0.00%) 		Mkt cap ! $5.64M
Open High Low Value Volume
3.9¢ 3.9¢ 3.9¢ $156 4K

Buyers (Bids)

No. Vol. Price($)
1 11000 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 180831 2
View Market Depth
Last trade - 10.07am 26/06/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.